HongFeng Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
HongFeng Liu has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Amol Muthal
Department of Pharmacology, Bharati Vidyapeeth (Deemed to be University, Poona College of Pharmacy, Erandwane, Pune, India
1 shared publication - Bong Hyo Lee
Department of Acupuncture, Moxibustion, and Acupoint, College of Korean Medicine, Daegu Haany University
1 shared publication - Chae Ha Yang
Department of Physiology, College of Korean Medicine, Daegu Haany University, Daegu, Republic of Korea
1 shared publication Chang Hyun Song
College of Oriental Medicine, Daegu Haany University, Daegu 706-060, Republic of Korea
1 shared publication- Chul Won Lee
Department of Sport Industry Studies, College of Educational Sciences, Yonsei University, Seoul 03722, Republic of Korea
1 shared publication - Il Je Cho
Central Research Center, Okchundang Inc., Daegu 41059, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 3 September 2026
- Published by Universidad del Zulia in Investigación Clínica
- Vol. 67 (3) , 349
Protective effects of apigenin on experimental biliary acute pancreatitis: Role of Insulin-like growth factor-binding protein 4, G protein-coupled bile acid receptor 1, and G protein-coupled receptor 39.
Biliary acute pancreatitis (BAP) has no specific pharmacotherapy beyond supportive care and stone removal. This study evaluated the protective ef-ficacy and putative molecular mechanisms of apigenin, a dietary flavonoid with an-tioxidant and anti-inflammatory properties, in an L -arginine-induced model of BAP in rats. Adult male Wistar rats (n=8/group) received oral vehicle (DMSO), meth-ylprednisolone (30 mg/kg), or apigenin (5, 10, or 20 mg/kg) for seven days, after BAP was induced (except in the normal group) by two intraperitoneal injections of 8% L -arginine (2.5 g/kg, 1 h apart). At the end of the study, various biomarkers were assessed. L -arginine produced pronounced pancreatic edema (p<0.001) and increased pancreatic weight; elevated serum amylase, lipase, and C-reactive protein; and concomitant hypocalcemia. It also increased pancreatic malondialdehyde and nitric oxide, depleted reduced glutathione and antioxidant enzyme activities (includ-ing catalase and superoxide dismutase), increased myeloperoxidase, and increased tumor necrosis factor-α, interleukin (IL)-1β, and IL -6. These changes were accompa-nied by severe inflammatory infiltration, edema, and necrosis, and by marked upreg-ulation of insulin-like growth factor-binding protein (IGFBP)-4, G protein-coupled bile acid receptor (GPBAR)-1, and G protein-coupled receptor (GPR)-39 mRNA (all p<0.001 vs. normal). Apigenin (10 and 20 mg/kg) dose-dependently reversed these biochemical and histological abnormalities and downregulated IGFBP4, GPR39, and GPBAR1 mRNA expression, with effects comparable to those of methylpred-nisolone. The expression of IGFBP4, GPBAR1, and GPR39 was positively correlated with amylase, lipase, and edema severity. In conclusion, these findings support api-genin as a multi-target adjunct candidate for BAP, acting by attenuating oxidonitro-sative stress, neutrophil-associated injury (IGFBP4 and GPBAR1), inflammatory cytokines, and disease-associated transcriptional programs (GPR39).
- 3 September 2026
- Published by Universidad del Zulia in Investigación Clínica
- Vol. 67 (3) , 349
Open AccessProtective effects of apigenin on experimental biliary acute pancreatitis: Role of Insulin-like growth factor-binding protein 4, G protein-coupled bile acid receptor 1, and G protein-coupled receptor 39.
Biliary acute pancreatitis (BAP) has no specific pharmacotherapy beyond supportive care and stone removal. This study evaluated the protective ef-ficacy and putative molecular mechanisms of apigenin, a dietary flavonoid with an-tioxidant and anti-inflammatory properties, in an L -arginine-induced model of BAP in rats. Adult male Wistar rats (n=8/group) received oral vehicle (DMSO), meth-ylprednisolone (30 mg/kg), or apigenin (5, 10, or 20 mg/kg) for seven days, after BAP was induced (except in the normal group) by two intraperitoneal injections of 8% L -arginine (2.5 g/kg, 1 h apart). At the end of the study, various biomarkers were assessed. L -arginine produced pronounced pancreatic edema (p<0.001) and increased pancreatic weight; elevated serum amylase, lipase, and C-reactive protein; and concomitant hypocalcemia. It also increased pancreatic malondialdehyde and nitric oxide, depleted reduced glutathione and antioxidant enzyme activities (includ-ing catalase and superoxide dismutase), increased myeloperoxidase, and increased tumor necrosis factor-α, interleukin (IL)-1β, and IL -6. These changes were accompa-nied by severe inflammatory infiltration, edema, and necrosis, and by marked upreg-ulation of insulin-like growth factor-binding protein (IGFBP)-4, G protein-coupled bile acid receptor (GPBAR)-1, and G protein-coupled receptor (GPR)-39 mRNA (all p<0.001 vs. normal). Apigenin (10 and 20 mg/kg) dose-dependently reversed these biochemical and histological abnormalities and downregulated IGFBP4, GPR39, and GPBAR1 mRNA expression, with effects comparable to those of methylpred-nisolone. The expression of IGFBP4, GPBAR1, and GPR39 was positively correlated with amylase, lipase, and edema severity. In conclusion, these findings support api-genin as a multi-target adjunct candidate for BAP, acting by attenuating oxidonitro-sative stress, neutrophil-associated injury (IGFBP4 and GPBAR1), inflammatory cytokines, and disease-associated transcriptional programs (GPR39).
- Open Access
- 1 January 2017
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2017 (1) , 4351723
Manual Acupuncture at PC6 Ameliorates Acute Restraint Stress‐Induced Anxiety in Rats by Normalizing Amygdaloid Noradrenergic Response
Acupuncture improves ethanol withdrawal‐induced anxiety in rats in an acupoint‐dependent manner. Thus, the present study investigated the effects of acupuncture on acute restraint stress‐ (ARS‐) induced anxiety. Male rats were exposed to ARS for 3 h followed by acupuncture at either PC6 (Neiguan), HT7 (Shenmen), or a nonacupoint (tail) once a day for three consecutive days. Five minutes after the third acupuncture treatment, anxiety‐like behavior was evaluated in an elevated plus maze (EPM). Additionally, plasma corticosterone (CORT) levels were measured by radioimmunoassay and the concentrations of norepinephrine (NE) and 3‐methoxy‐4‐hydroxy‐phenylglycol (MHPG) in the central nucleus of the amygdala (CeA) were determined using high‐performance liquid chromatography. Acupuncture at PC6, but not HT7 or a nonacupoint, attenuated anxiety‐like behavior, but this attenuation was abolished by a postacupunctural intra‐CeA infusion of NE. Acupuncture at PC6 also reduced the oversecretion of plasma CORT and inhibited increases in amygdaloid NE and MHPG induced by ARS. Further, Western blot analyses and real‐time polymerase chain reaction assays revealed that acupuncture at PC6 prevented ARS‐induced enhancements in the protein and mRNA expressions of tyrosine hydroxylase in the CeA. These results suggest that acupuncture performed specifically at acupoint PC6 reduces ARS‐induced anxiety‐like behavior by dampening amygdaloid noradrenergic responses.
- 1 January 2017
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2017 (1) , 4351723
Open AccessManual Acupuncture at PC6 Ameliorates Acute Restraint Stress‐Induced Anxiety in Rats by Normalizing Amygdaloid Noradrenergic Response
Acupuncture improves ethanol withdrawal‐induced anxiety in rats in an acupoint‐dependent manner. Thus, the present study investigated the effects of acupuncture on acute restraint stress‐ (ARS‐) induced anxiety. Male rats were exposed to ARS for 3 h followed by acupuncture at either PC6 (Neiguan), HT7 (Shenmen), or a nonacupoint (tail) once a day for three consecutive days. Five minutes after the third acupuncture treatment, anxiety‐like behavior was evaluated in an elevated plus maze (EPM). Additionally, plasma corticosterone (CORT) levels were measured by radioimmunoassay and the concentrations of norepinephrine (NE) and 3‐methoxy‐4‐hydroxy‐phenylglycol (MHPG) in the central nucleus of the amygdala (CeA) were determined using high‐performance liquid chromatography. Acupuncture at PC6, but not HT7 or a nonacupoint, attenuated anxiety‐like behavior, but this attenuation was abolished by a postacupunctural intra‐CeA infusion of NE. Acupuncture at PC6 also reduced the oversecretion of plasma CORT and inhibited increases in amygdaloid NE and MHPG induced by ARS. Further, Western blot analyses and real‐time polymerase chain reaction assays revealed that acupuncture at PC6 prevented ARS‐induced enhancements in the protein and mRNA expressions of tyrosine hydroxylase in the CeA. These results suggest that acupuncture performed specifically at acupoint PC6 reduces ARS‐induced anxiety‐like behavior by dampening amygdaloid noradrenergic responses.